Bradycardia, hypotension and bronchospasm following remifentanil-propofol in a myathenic paitent treated by pyridostigmine--a case report.
Nauphal
Maud
M
Dept. of Anesthesiology, American Univ. of Beirut Medical Center, Beirut, Lebanon. mnoo@aub.edu.lb
Baraka
Anis
A
D000328:Adult; D000768:Anesthesia, General / Q000009:adverse effects*; D018686:Anesthetics, Intravenous / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced; D001986:Bronchial Spasm / Q000139:chemically induced; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000601:surgery; D010880:Piperidines / Q000009:adverse effects*; D011229:Preanesthetic Medication; D015742:Propofol / Q000009:adverse effects*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D000077208:Remifentanil; D013934:Thymectomy
D018686:Anesthetics, Intravenous; D002800:Cholinesterase Inhibitors; D010880:Piperidines; D011729:Pyridostigmine Bromide; D000077208:Remifentanil; D015742:Propofol